GL1X · GenesisL1 explorer

MolNFT v1 · #63988 · protein

Design of an insulin analog with enhanced receptor-binding selectivity. rationale, structure, and therapeutic implications

3FQ9: “Design of an insulin analog with enhanced receptor-binding selectivity. rationale, structure, and therapeutic…”. X-ray diffraction, 1 ligand (ZN). MolNFT v1 #63988 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3FQ9
Type
protein
Length
102 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin
UniProt
P01308
Ligands
ZN

Structure

x-ray diffraction · 2 distinct chains · 55% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, CInsulinprotein2167% helix, 10% strandP01308
B, DInsulinprotein3047% helix, 13% strandP01308

Ligands and binding sites

  • ZN · Zinc ion · metal · 2 copies · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

5 interfaces between chains.

  • C–D · 925 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 917 Ų buried · 14 hydrogen bonds · protein-protein
  • B–D · 616 Ų buried · 6 hydrogen bonds · protein-protein
  • A–D · 65 Ų buried · 0 hydrogen bonds · protein-protein
  • B–C · 50 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide, 2 d-amino, 2 modified (disulfide, D-amino acid, nonstandard).

Compared structures

  • 3FQ9 · Design of an insulin analog with enhanced receptor-binding selectivity. Rationale… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.